UniSa - IRIS Institutional Research Information System

SABBATINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.065
NA - Nord America 3.180
EU - Europa 1.641
SA - Sud America 654
AF - Africa 71
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.624
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 3.816
US - Stati Uniti d'America 3.098
SG - Singapore 1.113
BR - Brasile 553
IT - Italia 459
CN - Cina 400
VN - Vietnam 323
RU - Federazione Russa 289
DE - Germania 258
TR - Turchia 101
FI - Finlandia 100
IE - Irlanda 100
IN - India 75
SE - Svezia 74
UA - Ucraina 69
KR - Corea 66
GB - Regno Unito 59
AT - Austria 52
AR - Argentina 48
CA - Canada 43
NL - Olanda 42
ID - Indonesia 33
ZA - Sudafrica 32
PL - Polonia 28
MX - Messico 26
FR - Francia 25
JP - Giappone 25
CZ - Repubblica Ceca 24
ES - Italia 23
BD - Bangladesh 19
EC - Ecuador 17
IQ - Iraq 16
NP - Nepal 11
UZ - Uzbekistan 10
LT - Lituania 9
PY - Paraguay 9
AL - Albania 8
IL - Israele 8
AZ - Azerbaigian 7
PE - Perù 7
TN - Tunisia 7
MA - Marocco 6
PK - Pakistan 6
SA - Arabia Saudita 6
TH - Thailandia 6
AU - Australia 5
CL - Cile 5
CO - Colombia 5
DZ - Algeria 5
EG - Egitto 5
GR - Grecia 5
KE - Kenya 5
KG - Kirghizistan 4
MY - Malesia 4
NZ - Nuova Zelanda 4
UY - Uruguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
IR - Iran 3
PA - Panama 3
RO - Romania 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CR - Costa Rica 2
GM - Gambi 2
JM - Giamaica 2
LB - Libano 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CV - Capo Verde 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
JO - Giordania 1
KI - Kiribati 1
MG - Madagascar 1
ML - Mali 1
MM - Myanmar 1
NA - Namibia 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
Totale 11.624
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.814
Singapore 524
Ann Arbor 377
Dallas 375
Chandler 304
Princeton 274
San Jose 236
Ashburn 231
Munich 192
Naples 110
Beijing 99
Dublin 95
Dong Ket 91
Izmir 91
Ho Chi Minh City 89
Jacksonville 88
Los Angeles 77
Moscow 73
Wilmington 69
Hanoi 57
Andover 56
Houston 56
Pellezzano 52
The Dalles 51
New York 50
São Paulo 46
Nuremberg 44
Helsinki 42
Salerno 34
Turku 34
Nanjing 32
Vienna 32
Woodbridge 30
Boardman 29
Warsaw 27
Brno 23
Denver 23
Tokyo 22
Fairfield 19
Fisciano 19
Poplar 19
Orem 17
Pune 17
Atlanta 16
Changsha 16
Chennai 16
Nanchang 16
Amsterdam 15
Boston 15
Brooklyn 15
San Francisco 15
Columbus 14
Norwalk 14
Rio de Janeiro 14
Johannesburg 13
Montreal 13
Santa Clara 13
Biên Hòa 12
Haiphong 12
Milan 12
Sarno 12
Brasília 11
Lappeenranta 11
Mumbai 11
Paris 11
Seattle 11
Seoul 11
Belo Horizonte 10
Council Bluffs 10
Manchester 10
Toronto 10
Chicago 9
Shanghai 9
Stockholm 9
Baronissi 8
Curitiba 8
Goiânia 8
Guarulhos 8
Jakarta 8
Jiaxing 8
Kathmandu 8
Phoenix 8
Quito 8
Ribeirão Preto 8
San Diego 8
Tashkent 8
Tel Aviv 8
Baku 7
Campinas 7
Domicella 7
Orange 7
Porto Alegre 7
Shenyang 7
Washington 7
Ankara 6
Baghdad 6
Bologna 6
Cambridge 6
Cape Town 6
Charlotte 6
Totale 8.615
Salva come PNG Salva come JPEG
Nome #
Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis 596
Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy 581
Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series 505
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors 491
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 454
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies 402
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC 290
The Current and Future Impact of Lymph Node Fine-Needle Aspiration Cytology on Patient Care 228
Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review 221
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 216
Proceedings of the XXII National Conference of the Italian Society of Cytometry GIC, October 4–8, 2005, San Bendetto del Tronto (AP), Italy 178
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms 176
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 163
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma 133
Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma 126
Abstract 3639: Combinatorial therapy for triple negative breast cancer 122
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer 121
Cell growth-inhibition and cell cycle perturbations induced by a new synthetic iminoquinone, 5H-pyridophenoxazin-5-one, in human breast carcinoma cell lines. 119
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 119
Inhibition of NF-kB activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells AACR Meeting Abstracts, Apr 2006; 2006: 1038. 115
Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation 114
Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two-years' experience 109
Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells 109
The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells. 107
597 IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 107
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2010. October 2-6, 2010. Valencia, Spain 104
Abstract 4741: Inhibition of TNBC cell growth by CSPG4-specific mAb 225.28 with a Sonic Hedgehog pathway inhibitor 102
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2011. September 10-14, 2011. Munich, Germany 99
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 96
Counteracting resistance to treatments in solid tumors. 95
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy 94
Blocking the formation of radiation-induced breast cancer stem cells 94
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram 92
XXV Conferenza Nazionale di Citometria: CELL GROWTH INHIBITION AND CELL CYCLE PERTURBATIONS INDUCED BY A NEW SYNTHETIC IMINOQUINONE, 5H-PYRIDOPHENOXAZIN-5-ONE, IN HUMAN BREAST CARCINOMA CELL LINES 92
Multidisciplinary approach to patient with malignant melanoma 89
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy 88
Immune Checkpoint Inhibitors in Melanoma and HIV Infection 87
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 87
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches 86
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation. 86
Ipilimumab in the treatment of metastatic melanoma: Management of adverse events 85
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase i inhibitor or radiation 84
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma 83
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 83
PD-L1 Dysregulation in COVID-19 Patients 83
"Idealized" vs. "true" learning curves: The case of laparoscopic liver resection 82
XXV Conferenza Nazionale di Citometria: INHIBITION OF POLY (ADP-RIBOSE) POLYMERASE SYNERGIZES WITH THE DNA-TOPOISOMERASE-1-INHIBITOR, TOPOTECAN, AND RADIATION IN HUMAN GLIOBLASTOMA CELL LINE 80
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in advanced cancer patients treated with anti-PD-1/PD-L1 therapy 78
Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice 78
Epigenetic control of gene expression: Potential implications for cancer treatment 78
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology 78
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review 77
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 77
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 76
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors 73
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? 72
Surgical Treatment, Rehabilitative Approaches and Functioning Assessment for Patients Affected by Breast Cancer-Related Lymphedema: A Comprehensive Review 71
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 71
P.1.112: IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 71
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives 71
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 70
Harnessing host innate immunity may combat acquired resistance to BRAFi 69
P.1.159: REPEATED LOCO-REGIONAL TREATMENTS: HIGH SURVIVAL RATES IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA HIGHLY COMPLIANT TO SCHEDULED FOLLOW-UP 69
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 68
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 68
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 66
Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence 64
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature 64
PD-L1 and HLA class i antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma 63
Variability in immune infiltrates and HLA expression in cholangiocarcinoma 63
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma 63
Diagnosis of Langerhans cell histiocytosis on cytological examination of cerebrospinal fluid: Report of the first case 62
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives 62
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells 61
Emerging BRAF inhibitors for melanoma 61
Tissue micro arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma 60
P.1.279: ADVANCED HCC ABLATION AFTER DOWSTAGING WITH SORAFENIB 59
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation 59
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 57
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer 57
Testing egfr with idylla on cytological specimens of lung cancer: A review 57
Melanoma initiating cells: where do we stand? 56
Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96 56
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells 56
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 56
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation 55
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study 54
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors 53
Advancing the integration of biosignal-based automated pain assessment methods into a comprehensive model for addressing cancer pain 51
PHH3 immunostaining: a novel prognostic biomarker in pancreatic neuroendocrine tumors 50
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors 49
Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma 48
Genetic evolution of T-cell resistance in the course of melanoma progression 47
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 47
The ratio of grzb+ − foxp3+ over cd3+ t cells as a potential predictor of response to nivolumab in patients with metastatic melanoma 45
Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review 44
The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis 42
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy 42
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy 42
Emerging treatment approaches for triple-negative breast cancer 40
Totale 11.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.554
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 0 21 3 7 1 20 108
2021/2022462 7 0 2 1 22 5 2 19 79 50 66 209
2022/2023752 77 80 68 128 55 144 1 48 98 1 42 10
2023/2024555 41 42 37 37 37 59 44 29 35 37 29 128
2024/20251.792 44 17 28 66 90 195 322 138 335 141 198 218
2025/20267.030 792 2.229 1.769 681 741 432 386 0 0 0 0 0
Totale 11.903